Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00117494 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)

StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Dec 21, 2011, no change to tracked fieldsv8-v9
  2. Study title expanded, about 1 wordv7 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Active, Not Recruiting to Completed Primary completion date: Mar 2007 · Completion date: Jun 2007v6 Show all 3 changesShow less
    • Primary completion date: Mar 2007
    • Completion date: Jun 2007
  4. Trial status: Recruiting to Active, Not Recruiting Site details revisedv5 Show all 2 changesShow less
    • Site details revised
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Start date: Oct 2005 · Site details revisedv3 Show all 3 changesShow less
    • Start date: Oct 2005
    • Site details revised
  2. Study Identification, Study Status, Conditionsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In HIV hypercholesterolemic patients treated with protease inhibitors, some drugs of the statin group are used to control cholesterol level. New and potentially more efficient statins may interfere with protease inhibitors and hence loose a part of their activity. They have thus to be compared with a more established drug of the same class (e.g. pravastatin). The protocol compares the efficacy and safety of rosuvastatin and pravastatin.
Trial Details
NCT Number NCT00117494
Lead Sponsor French National Agency for Research on AIDS and Viral Hepatitis
Conditions Hyperlipidemia, HIV Infections
Enrollment 86 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov